Dose-Dependent Increase in Intratesticular Testosterone by Very Low-Dose Human Chorionic Gonadotropin in Normal Men with Experimental Gonadotropin Deficiency
Mara Y. Roth(University of Washington), John K. Amory(University of Washington), Bradley D. Anawalt(University of Washington), Alvin M. Matsumoto(University of Washington), Kelvin Lin(University of Washington), S. T. Page(University of Washington), C. N. Snyder(University of Washington), W. J. Bremner(University of Washington), Brett T. Marck(VA Puget Sound Health Care System)
Cited by 64
Related Papers
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|1.6k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
|Genes & Development|1998|650
Prevalence and Incidence of Androgen Deficiency in Middle-Aged and Older Men: Estimates from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2004|588
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514